Details

Lokalne volitve v Republiki Sloveniji v letu 2014 : diplomsko delo
ID Repnik, Tomaž (Author), ID Kocjančič, Rudi (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (580,48 KB)
MD5: 548DA230DFD4043B193C008BE5CEF949
PID: 20.500.12556/rul/b9a0c266-5dc4-414f-96ea-1024e7560311

Language:Slovenian
Keywords:volitve, lokalne volitve, Slovenija, diplomske naloge
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FU - Faculty of Administration
Place of publishing:Ljubljana
Publisher:[T. Repnik]
Year:2016
Number of pages:IX, 46 str.
PID:20.500.12556/RUL-89456 This link opens in a new window
UDC:342.8:352(497.4)(043.2)
COBISS.SI-ID:4915374 This link opens in a new window
Publication date in RUL:29.03.2017
Views:1851
Downloads:275
Metadata:XML DC-XML DC-RDF
:
REPNIK, Tomaž, 2016, Lokalne volitve v Republiki Sloveniji v letu 2014 : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : T. Repnik. [Accessed 29 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=89456
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
  5. Diabetes mellitus and physical activity
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back